Literature DB >> 17699576

Role for amino acids 212KLR214 of Ebola virus VP40 in assembly and budding.

Sarah E McCarthy1, Reed F Johnson, Yong-An Zhang, J Oriol Sunyer, Ronald N Harty.   

Abstract

Ebola virus VP40 is able to produce virus-like particles (VLPs) in the absence of other viral proteins. At least three domains within VP40 are thought to be required for efficient VLP release: the late domain (L-domain), membrane association domain (M-domain), and self-interaction domain (I-domain). While the L-domain of Ebola VP40 has been well characterized, the exact mechanism by which VP40 mediates budding through the M- and I-domains remains unclear. To identify additional domains important for VP40 assembly/budding, amino acids (212)KLR(214) were targeted for mutagenesis based on the published crystal structure of VP40. These residues are part of a loop connecting two beta sheets in the C-terminal region and thus are potentially important for overall structure and/or oligomerization of VP40. A series of alanine substitutions were generated in the KLR region of VP40, and these mutants were examined for VLP budding, intracellular localization, and oligomerization. Our results indicated that (i) (212)KLR(214) residues of VP40 are important for efficient release of VP40 VLPs, with Leu213 being the most critical; (ii) VP40 KLR mutants displayed altered patterns of cellular localization compared to that of wild-type VP40 (VP40-WT); and (iii) self-assembly of VP40 KLR mutants into oligomers was altered compared to that of VP40-WT. These results suggest that (12)KLR(214) residues of VP40 are important for proper assembly/oligomerization of VP40 which subsequently leads to efficient budding of VLPs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699576      PMCID: PMC2045517          DOI: 10.1128/JVI.00853-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Cleavage of vesicular stomatitis virus matrix protein prevents self-association and leads to crystallization.

Authors:  M Gaudier; Y Gaudin; M Knossow
Journal:  Virology       Date:  2001-09-30       Impact factor: 3.616

2.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

Authors:  Jillian M Licata; Martha Simpson-Holley; Nathan T Wright; Ziying Han; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Oligomerization and polymerization of the filovirus matrix protein VP40.

Authors:  Joanna Timmins; Guy Schoehn; Christine Kohlhaas; Hans-Dieter Klenk; Rob W H Ruigrok; Winfríed Weissenhorn
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

5.  A morphological study of the M-protein of Sendai virus.

Authors:  J A Hewitt; M V Nermut
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

6.  Intramembrane structural differentiation in Sendai virus maturation.

Authors:  T Bächi
Journal:  Virology       Date:  1980-10-15       Impact factor: 3.616

7.  Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Authors:  Takeshi Noda; Hiroshi Sagara; Emiko Suzuki; Ayato Takada; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.

Authors:  Rekha G Panchal; Gordon Ruthel; Tara A Kenny; George H Kallstrom; Douglas Lane; Shirin S Badie; Limin Li; Sina Bavari; M Javad Aman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

Review 9.  Pathogenesis of filoviral haemorrhagic fevers.

Authors:  Siddhartha Mahanty; Mike Bray
Journal:  Lancet Infect Dis       Date:  2004-08       Impact factor: 25.071

10.  Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles.

Authors:  Jillian M Licata; Reed F Johnson; Ziying Han; Ronald N Harty
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more
  26 in total

1.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

2.  Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.

Authors:  T Hoenen; N Biedenkopf; F Zielecki; S Jung; A Groseth; H Feldmann; S Becker
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

3.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

Review 4.  Advances in virus-like particle vaccines for filoviruses.

Authors:  Kelly L Warfield; M Javad Aman
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses.

Authors:  Ziying Han; Jianhong Lu; Yuliang Liu; Benjamin Davis; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Matthias J Schnell; Jay E Wrobel; Allen B Reitz; Ronald N Harty
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

6.  Interdomain salt-bridges in the Ebola virus protein VP40 and their role in domain association and plasma membrane localization.

Authors:  Jeevan B Gc; Kristen A Johnson; Monica L Husby; Cary T Frick; Bernard S Gerstman; Robert V Stahelin; Prem P Chapagain
Journal:  Protein Sci       Date:  2016-07-04       Impact factor: 6.725

7.  Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Authors:  Marc Schweneker; Andrea S Laimbacher; Gert Zimmer; Susanne Wagner; Elisabeth M Schraner; Michael Wolferstätter; Marieken Klingenberg; Ulrike Dirmeier; Robin Steigerwald; Henning Lauterbach; Hubertus Hochrein; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

8.  A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress.

Authors:  Jianhong Lu; Ziying Han; Yuliang Liu; Wenbo Liu; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  The Ebola virus matrix protein VP40 selectively induces vesiculation from phosphatidylserine-enriched membranes.

Authors:  Smita P Soni; Robert V Stahelin
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

10.  Marburg virus evades interferon responses by a mechanism distinct from ebola virus.

Authors:  Charalampos Valmas; Melanie N Grosch; Michael Schümann; Judith Olejnik; Osvaldo Martinez; Sonja M Best; Verena Krähling; Christopher F Basler; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.